The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
osiris therapeutics | 277 |
mesoblast international | 72 |
inflabloc pharmaceuticals | 6 |
medigenes | 2 |
mesoblast internation | 1 |
charles r. mills | 1 |
osiris therapeutics | 34 |
medigenes | 1 |
inflabloc pharmaceuticals | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
mesenchymal stem cells and uses therefor | 60 | 2004 |
methods of manufacture of immunocompatible amniotic membrane products | 57 | 2010 |
porated cartilage products | 37 | 2012 |
purified mesenchymal stem cell compositions and methods of purifying mesenchymal stem ce… 🛈 | 29 | 2008 |
cardiac muscle regeneration using mesenchymal stem cells | 27 | 1997 |
mesenchymal stem cells expressing tnf-alpha receptor | 23 | 2006 |
joint repair using mesenchymal stem cells | 20 | 2000 |
use of mesenchymal stem cells for treating genetic diseases and disorders | 16 | 2006 |
enhanced msc preparations | 14 | 2010 |
mesenchymal stem cells and uses therefor | 13 | 2004 |